Monoclonal antibodies in the treatment of cancer, Part 1
RJ Cersosimo - American journal of health-system pharmacy, 2003 - academic.oup.com
Monoclonal antibodies used in the treatment of cancer are discussed. Monoclonal
antibodies are a new class of agents targeted at specific receptors on cancer cells. In …
antibodies are a new class of agents targeted at specific receptors on cancer cells. In …
Antibody therapy of non-Hodgkin's B-cell lymphoma
P Chinn, G Braslawsky, C White, N Hanna - Cancer Immunology …, 2003 - Springer
Engineering antibodies with reduced immunogenicity and enhanced effector functions, and
selecting antigen targets with the appropriate specificity, density, and/or functionality, have …
selecting antigen targets with the appropriate specificity, density, and/or functionality, have …
[PDF][PDF] VYUÎITÍ RITUXIMABU V LÉâBų CHRONICKÉ LYMFATICKÉ LEUKEMIE RITUXIMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA
J Mayer, M Doubek, Y Brychtová… - … THE JOURNAL OF THE …, 2003 - linkos.cz
The treatment options for chronic lymphocytic leukemia (CLL) have dramatically increased
in the last few years. Promising results have been reported with new cytotoxic agents such …
in the last few years. Promising results have been reported with new cytotoxic agents such …
Clinical Studies of Immunotherapy With Rituximab (Rituxan®) and Radioimmunotherapy With Ibritumomab Tiuxetan (Zevalin®) in B-Cell Lymphoid Malignancies
A Molina - The Oncogenomics Handbook, 2005 - Springer
The introduction of the monoclonal antibody rituximab has expanded the treatment options
for patients with B-cell non-Hodgkin's lymphoma (NHL). In patients with indolent B-cell …
for patients with B-cell non-Hodgkin's lymphoma (NHL). In patients with indolent B-cell …
[PDF][PDF] VYUÎITÍ RITUXIMABU V LÉâBù CHRONICKÉ LYMFATICKÉ LEUKEMIE RITUXIMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA
J MAYER, M DOUBEK, Y BRYCHTOVÁ… - KLINICKÁ …, 2003 - linkos.cz
The treatment options for chronic lymphocytic leukemia (CLL) have dramatically increased
in the last few years. Promising results have been reported with new cytotoxic agents such …
in the last few years. Promising results have been reported with new cytotoxic agents such …